The Epidemiological Study on Psychiatric Disorders & Psychotropic Drugs

Status Active, not recruiting

Clinical Trial Summary

During the past decade, the dramatic change in patterns of both psychiatric diagnoses and prescription of psychotropic agents has been noted since the introduction of newer antidepressant drugs. In the meantime, suicide has been recognized as a major public health problem all over the world. Research efforts have hence been spent in exploring the interrelationships between suicide rates and prescription of antidepressant drugs (as a proxy for the treatment of depression). However, most available studies came from developed countries despite that the majority of countries with rising suicide rates during the past decade were developing countries. Both suicide rates and prescription of antidepressant agents have been rising in Taiwan during the past decade; with a reliable mortality registrar and nationwide health insurance covering 99% of its population, Taiwan is distinctive in realizing a large-scale analysis on these interrelationships between suicide and prescription of antidepressant drugs. However, there has been no study in Taiwan exploring these potential associations up to now.

This study aims at examining the interrelationships between suicide rates and prescription of antidepressant agents based on the health insurance data from persons who had diagnoses of ICD: 290-319 or were prescribed with antidepressant agents during the period from 1998 to 2006. The investigators plan to first perform correlation analyses between the trends of suicide rates and prescription of antidepressants during the study period after taking into accounts potential confounding factors; analyses by age, gender groups and by administrative regions will also be performed. Besides, the investigators plan to analyze the change in the prescription pattern of psychotropic agents in Taiwan during the study period, with the particular focus on that of newer antidepressant drugs. The prescription of psychotropic agents in both psychiatric and non-psychiatric diagnoses will be explored.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00982943
Study type	Observational
Source	Far Eastern Memorial Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2009
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00166764` - A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders	N/A
Recruiting	`NCT06062953` - Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia	Phase 2/Phase 3
Recruiting	`NCT05548946` - A Dimensional Model for Personality Disorders in Later Life	N/A
Completed	`NCT03313154` - Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
Completed	`NCT00783783` - CYP2D6 Pharmacogenetics in Risperidone-Treated Children	N/A
Completed	`NCT01989728` - Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence	N/A
Completed	`NCT03125083` - Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus	N/A
Recruiting	`NCT01066299` - Influence of Oxytocin on the Startle Reflex and on Its Modulation	N/A
Completed	`NCT02987426` - Can Brief-mindfulness Interventions Improve Psychiatric Symptoms?	Phase 2/Phase 3
Recruiting	`NCT05784818` - Up To Me: Erasing the Stigma of Mental Illness on College Campuses	N/A
Completed	`NCT01786733` - Behavioral Activation - From Inpatient to Outpatient Services	N/A
Withdrawn	`NCT03907124` - Clinical Utility of Pharmacogenomics of Psychotropic Medications	Phase 4
Withdrawn	`NCT03809897` - Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders	Phase 4
Not yet recruiting	`NCT02857322` - Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative	N/A
Terminated	`NCT02665988` - Adjunctive Transcranial Direct Current Stimulation	N/A
Completed	`NCT01289080` - Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects	Phase 1
Completed	`NCT01823250` - Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial	Phase 2
Completed	`NCT00184340` - Secured Internet-mediated Psychotherapy With Psychiatry Patients	N/A
Completed	`NCT00184327` - Changes Following Inpatient Child-oriented Family Treatment	Phase 1
Recruiting	`NCT04381845` - Immunity and Infections in the Psychiatric Population	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Epidemiological Study on Psychiatric Disorders and Psychotropic Drugs

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms